Arena Pharmaceuticals, Inc. (ARNA) Financial Statements (2024 and earlier)

Company Profile

Business Address 6154 NANCY RIDGE DRIVE
SAN DIEGO, CA 92121
State of Incorp. DE
Fiscal Year End December 31
Industry (SIC) 2834 - Pharmaceutical Preparations (benchmarking)
More info Complete Financial Analysis Financial Benchmarking

Balance Sheet (Statement of Financial Position) ($ in thousands)

12/31/2021
Q4
9/30/2021
Q3
6/30/2021
Q2
3/31/2021
Q1
12/31/2020
Q4
9/30/2020
Q3
6/30/2020
Q2
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments, including: 800,0001,000,0001,100,0001,104,0411,167,8641,170,634
Cash and cash equivalents 386,653514,177432,978219,544460,145550,176
Short-term investments 385,014457,359655,846884,497707,719620,458
Other undisclosed cash, cash equivalents, and short-term investments 28,33328,46411,176   
Other undisclosed current assets (9,080)(9,565)21,60535,26634,38333,296
Total current assets: 790,920990,4351,121,6051,139,3071,202,2471,203,930
Noncurrent Assets
Property, plant and equipment 19,55820,38821,12922,09022,91323,769
Long-term investments and receivables 52,95334,419  33,28694,838
Long-term investments 52,95334,419  33,28694,838
Other noncurrent assets 37,59639,41741,20229,32317,09717,213
Total noncurrent assets: 110,10794,22462,33151,41373,296135,820
TOTAL ASSETS: 901,0271,084,6591,183,9361,190,7201,275,5431,339,750
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities 30,03723,41721,98035,35126,69718,339
Employee-related liabilities 15,87810,4456,77718,84615,29711,249
Accounts payable 6,9373,7859,54712,0047,6812,155
Accrued liabilities 7,2229,1875,6564,5013,7194,935
Other undisclosed current liabilities 23,31841,42025,52722,72625,19923,532
Total current liabilities: 53,35564,83747,50758,07751,89641,871
Noncurrent Liabilities
Liabilities, other than long-term debt 9,4669,96210,41010,96311,35211,744
Other liabilities 9,4669,96210,41010,96311,35211,744
Other undisclosed noncurrent liabilities    41,211  
Total noncurrent liabilities: 9,4669,96210,41052,17411,35211,744
Total liabilities: 62,82174,79957,917110,25163,24853,615
Equity
Equity, attributable to parent 800,721971,0801,085,9921,080,4691,169,9271,242,637
Common stock 666666
Additional paid in capital 2,769,1482,743,2252,711,9302,587,4942,553,9392,528,112
Accumulated other comprehensive income 122922047001,5522,651
Accumulated deficit (1,968,555)(1,772,243)(1,626,148)(1,507,731)(1,385,570)(1,288,132)
Total equity: 800,721971,0801,085,9921,080,4691,169,9271,242,637
Other undisclosed liabilities and equity 37,48538,78040,027 42,36843,498
TOTAL LIABILITIES AND EQUITY: 901,0271,084,6591,183,9361,190,7201,275,5431,339,750

Income Statement (P&L) ($ in thousands)

12/31/2021
Q4
9/30/2021
Q3
6/30/2021
Q2
3/31/2021
Q1
12/31/2020
Q4
9/30/2020
Q3
6/30/2020
Q2
Revenues    3720 
Gross profit:    3720 
Operating expenses (194,485)(144,391)(131,993)(135,338)(98,822)(87,823)
Operating loss: (194,485)(144,391)(131,993)(135,301)(98,802)(87,823)
Nonoperating income (expense) (1,827)(1,704)13,57613,1401,3642,895
Investment income, nonoperating 20532814,55914,1711,8253,065
Other nonoperating income (expense) (1,001)(981)9065659974
Interest and debt expense (1,031)(1,051)(1,073)(1,096)(1,120)(1,144)
Loss from continuing operations before equity method investments, income taxes: (197,343)(147,146)(119,490)(123,257)(98,558)(86,072)
Other undisclosed income from continuing operations before income taxes    1,0961,1201,144
Loss from continuing operations: (197,343)(147,146)(119,490)(122,161)(97,438)(84,928)
Loss before gain (loss) on sale of properties:(197,343)(147,146)(119,490)(122,161)(97,438)(84,928)
Net loss: (197,343)(147,146)(119,490)(122,161)(97,438)(84,928)
Other undisclosed net income attributable to parent 1,0311,0511,073   
Net loss available to common stockholders, diluted: (196,312)(146,095)(118,417)(122,161)(97,438)(84,928)

Comprehensive Income ($ in thousands)

12/31/2021
Q4
9/30/2021
Q3
6/30/2021
Q2
3/31/2021
Q1
12/31/2020
Q4
9/30/2020
Q3
6/30/2020
Q2
Net loss: (197,343)(147,146)(119,490)(122,161)(97,438)(84,928)
Other comprehensive income (loss) (44)(162)(331)(944)(1,151)2,495
Comprehensive loss: (197,387)(147,308)(119,821)(123,105)(98,589)(82,433)
Other undisclosed comprehensive income, net of tax, attributable to parent 1,1051,101908925231
Comprehensive loss, net of tax, attributable to parent: (196,282)(146,207)(118,913)(123,013)(98,537)(82,402)

Statements Sources

The financial statements are based on the Company's filings with the U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: